Here are 5 interesting findings from the July 2019 issue of AJMC®.
Hi, I’m Christina Mattina for The American Journal of Managed Care®. Here are 5 findings from research published in the July issue.
What Are the Potential Savings From Steering Patients to Lower-Priced Providers? A Static Analysis
1. A claims analysis found variation in prices for shoppable services, especially lab testing, and determined that switching patients to providers with the median price in their market could result in substantial savings on lab tests, imaging, and medical equipment.
Number of Manufacturers and Generic Drug Pricing From 2005 to 2017
2. By evaluating both price changes and pharmacy claims counts for generic drugs, researchers found that drug price increases are now affecting widely used multisource drugs, not just single-source drugs, which suggests that prices are becoming less responsive to competition.
Insurers’ Perspectives on MA Value-Based Insurance Design Model
3. Most insurers that were eligible to join the Medicare Advantage VBID model test did not do so, citing concerns around return on investment, information technology problems, and model parameters. Those that did participate often encountered these barriers but then overcame them.
Heroin and Healthcare: Patient Characteristics and Healthcare Prior to Overdose
4. Nearly all insured patients who overdose on heroin accessed healthcare services in the 6 months before their overdose, indicating opportunities to introduce prevention efforts in outpatient settings, and emphasizing the importance of coordinated care.
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence
5. Implementation of a co-pay accumulator adjustment program was associated with reduced adherence to specialty autoimmune drugs and higher rates of treatment discontinuation. Although these programs can save employers money in the short term, lower adherence can result in greater medical spending over time.
To read all of these studies and more, visit AJMC.com.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More